1. Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab 2010;95:1487–1495. PMID:
20375216.
2. Bondy CA. Turner Syndrome Study Group. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007;92:10–25. PMID:
17047017.
3. Baxter L, Bryant J, Cave CB, Milne R. Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev 2007;(1):CD003887. PMID:
17253498.
4. Quigley CA, Crowe BJ, Anglin DG, Chipman JJ. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 2002;87:2033–2041. PMID:
11994337.
5. Ranke MB, Partsch CJ, Lindberg A, Dorr HG, Bettendorf M, Hauffa BP, et al. Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. Eur J Endocrinol 2002;147:625–633. PMID:
12444894.
6. Hamelin CE, Anglin G, Quigley CA, Deal CL. Genomic imprinting in Turner syndrome: effects on response to growth hormone and on risk of sensorineural hearing loss. J Clin Endocrinol Metab 2006;91:3002–3010. PMID:
16757526.
7. Ranke MB, Lindberg A, Ferrandez Longas A, Darendeliler F, Albertsson-Wikland K, Dunger D, et al. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS. Pediatr Res 2007;61:105–110. PMID:
17211150.
8. Hughes IP, Choong CS, Harris M, Ambler GR, Cutfield WS, Hofman PL, et al. Growth hormone treatment for Turner syndrome in Australia reveals that younger age and increased dose interact to improve response. Clin Endocrinol (Oxf) 2011;74:473–480. PMID:
21375553.
9. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, et al. KIGS International Board. Kabi International Growth Study. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. J Clin Endocrinol Metab 2000;85:4212–4218. PMID:
11095456.
10. van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, et al. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 2003;88:1119–1125. PMID:
12629094.
11. Park MH, Kim KS, Lee HJ, Cho YM, Lee HK, Park KS, et al. Allelic frequencies and heterozygosities of microsatellite markers covering the whole genome in the Korean. J Hum Genet 2008;53:254–266. PMID:
18259685.
12. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child 1985;60:932–935. PMID:
4062345.
13. Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, Seo JW, et al. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr 2008;51:1–25.
14. Long JS, Ervin LH. Using heteroscedasticity consistent standard errors in the linear regression model. Am Stat 2000;54:217–224.
15. Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, Guerra R, et al. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet 1998;63:1757–1766. PMID:
9837829.
16. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005;434:400–404. PMID:
15772666.
17. Sagi L, Zuckerman-Levin N, Gawlik A, Ghizzoni L, Buyukgebiz A, Rakover Y, et al. Clinical significance of the parental origin of the X chromosome in turner syndrome. J Clin Endocrinol Metab 2007;92:846–852. PMID:
17192299.
18. Giltay JC, Maiburg MC. Klinefelter syndrome: clinical and molecular aspects. Expert Rev Mol Diagn 2010;10:765–776. PMID:
20843200.
19. de la Chapelle A. Analytic review: nature and origin of males with XX sex chromosomes. Am J Hum Genet 1972;24:71–105. PMID:
4622299.
20. Ogata T, Matsuo N. Comparison of adult height between patients with XX and XY gonadal dysgenesis: support for a Y specific growth gene(s). J Med Genet 1992;29:539–541. PMID:
1518022.
21. Salo P, Kaariainen H, Page DC, de la Chapelle A. Deletion mapping of stature determinants on the long arm of the Y chromosome. Hum Genet 1995;95:283–286. PMID:
7868119.
22. Kirsch S, Weiss B, De Rosa M, Ogata T, Lombardi G, Rappold GA. FISH deletion mapping defines a single location for the Y chromosome stature gene, GCY. J Med Genet 2000;37:593–599. PMID:
10922386.
23. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 1997;82:550–555. PMID:
9024252.
24. Thangavel C, Shapiro BH. A molecular basis for the sexually dimorphic response to growth hormone. Endocrinology 2007;148:2894–2903. PMID:
17332060.